About City of Hope

City of Hope is an independent biomedical research and treatment organization for cancer, diabetes, and other life-threatening diseases.

Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their health care partners by providing access to City of Hope’s specialized cancer expertise.

A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.

City of Hope’s commitment to Diversity, Equity, and Inclusion

We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds, and experiences to our work -- and that our teams align with the people we serve to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds, and perspectives; this is reflected in our work and represented in our people.

Position Summary

A Postdoctoral Fellowship opportunity is immediately available for the highly motivated individual in the research group of Dr. Sumanta Pal, at the Beckman Research Institute and Department of Medical Oncology of City of Hope, a prestigious NCI-designated Comprehensive Cancer Center.

The candidate will directly work on projects focused on genitourinary cancers, specifically kidney, bladder, and prostate cancers. This includes developing and maintaining clinical and translational research trials in genitourinary cancers, collecting, analyzing, and maintaining large databases pertaining to genitourinary cancers, drafting original research and review articles and publishing in peer reviewed journals, and developing and presenting abstracts at national and international conferences

Basic education, experience and skills required for consideration:

· PhD or M.D. in life or biomedical sciences, or a related discipline is required, though an M.D. and completion of an internal medicine residency is preferred.

· Experience in medical oncology is preferred

· Solid understanding of statistical methods and clinical and translational research procedures

· Proficient in written and spoken English

Additional Information:

As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.

· For more information on Dr. Sumanta Pal please visit here: https://www.cityofhope.org/sumanta-pal

· For a complete list of Dr. Pal’s publications, please visit here: https://pubmed.ncbi.nlm.nih.gov/?term=pal,+sumanta